Taiwan Liposome Company Ltd (TLC, 台灣微脂體) announced yesterday that it would introduce its ProFlow product to Japan in cooperation with Japanese pharmaceutical retailer Nihon Generic Co.
The pact will make ProFlow the first drug developed by Taiwanese to enter a leading international pharmaceutical manufacturing market under its private brand.
TLC said the Japanese market for Prostaglandin E1 (PGE1) — a major ingredient of ProFlow — is worth NT$10 billion (US$329 million).
It is estimated that ProFlow will be able to obtain a 45 percent market share in Japan within five years of its launch.
“The Taiwanese market is rather small, so it is important for us to expand our overseas market,” said Keelung Hong (洪基隆), TLC founder and chairman, at a press conference yesterday.
Japan is the second-largest pharmaceutical market in the world after the US, and is rather difficult to enter, Hong said.
Since TLC lacks the resources to market its products overseas, the deal with Nihon Generic is a crucial step for TLC in entering the international market.
The company has plans to enter the South Korean and Chinese markets, which have market values of NT$500 million and NT$1.5 billion respectively, Hong said.
TLC’s announcement came as Bio Taiwan, Asia’s largest biotechnology trade fair, opened in Taipei, showcasing cutting-edge medical and healthcare products.
The trade fair is being held alongside a healthcare and biomedical cosmetology exposition.
The two shows will run through Sunday and feature nearly 430 manufacturers at 850 booths at Taipei World Trade Center’s Exhibition Hall 1. The two shows are expected to attract 80,000 visitors.
Many pharmaceutical and biotech companies are showcasing their latest biotechnology products.
PhytoHealth Corp (懷特新藥科技), a Taiwanese firm listed on the local stock market, is presenting PHNO12 (PG2), a complementary and alternative medicine for treating advanced-stage cancer patients.
SunTen Phytotech (順天生物科技), which will soon go public in Taipei, is showcasing its biotechnology innovations, which include traditional Chinese medicines.
In other developments, International Technical and Brains Services (ITBS), a Japanese biomedical manufacturer, signed a Memorandum of Understanding (MOU) at the show with a Taiwanese company, Medigreen Biotechnology Corp (鴻亞生物科技), to collaborate on production and marketing in both countries.
Showcasing its ginseng fruits, ITBS president Sei Tomio claimed the product could help “cure” AIDS, cancers and normalize body conditions.
SEEKING CLARITY: Washington should not adopt measures that create uncertainties for ‘existing semiconductor investments,’ TSMC said referring to its US$165 billion in the US Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) told the US that any future tariffs on Taiwanese semiconductors could reduce demand for chips and derail its pledge to increase its investment in Arizona. “New import restrictions could jeopardize current US leadership in the competitive technology industry and create uncertainties for many committed semiconductor capital projects in the US, including TSMC Arizona’s significant investment plan in Phoenix,” the chipmaker wrote in a letter to the US Department of Commerce. TSMC issued the warning in response to a solicitation for comments by the department on a possible tariff on semiconductor imports by US President Donald Trump’s
The government has launched a three-pronged strategy to attract local and international talent, aiming to position Taiwan as a new global hub following Nvidia Corp’s announcement that it has chosen Taipei as the site of its Taiwan headquarters. Nvidia cofounder and CEO Jensen Huang (黃仁勳) on Monday last week announced during his keynote speech at the Computex trade show in Taipei that the Nvidia Constellation, the company’s planned Taiwan headquarters, would be located in the Beitou-Shilin Technology Park (北投士林科技園區) in Taipei. Huang’s decision to establish a base in Taiwan is “primarily due to Taiwan’s talent pool and its strength in the semiconductor
Industrial production expanded 22.31 percent annually last month to 107.51, as increases in demand for high-performance computing (HPC) and artificial intelligence (AI) applications drove demand for locally-made chips and components. The manufacturing production index climbed 23.68 percent year-on-year to 108.37, marking the 14th consecutive month of increase, the Ministry of Economic Affairs said. In the first four months of this year, industrial and manufacturing production indices expanded 14.31 percent and 15.22 percent year-on-year, ministry data showed. The growth momentum is to extend into this month, with the manufacturing production index expected to rise between 11 percent and 15.1 percent annually, Department of Statistics
An earnings report from semiconductor giant and artificial intelligence (AI) bellwether Nvidia Corp takes center stage for Wall Street this week, as stocks hit a speed bump of worries over US federal deficits driving up Treasury yields. US equities pulled back last week after a torrid rally, as investors turned their attention to tax and spending legislation poised to swell the US government’s US$36 trillion in debt. Long-dated US Treasury yields rose amid the fiscal worries, with the 30-year yield topping 5 percent and hitting its highest level since late 2023. Stocks were dealt another blow on Friday when US President Donald
RSS